Please take note of the agenda for the upcoming virtual
Joint Basel Epidemiology Seminar and Basel Biometrics Society on
Impact of the Covid-19 pandemic on drug utilization and outcome measurements
Date and time:
- November 23rd, 2021
- 14:00-17:30 CET
Venue:
Virtual event
Registration:
- Free of charge
- Please register
- The participation link will be shared upon registration.
Agenda
14:00 – 14:15 Andrea Burden (ETH Zurich)
Welcome & Introduction
14:15 – 15:00 Tara Gomes (University of Toronto)
Understanding the impacts of the COVID-19 pandemic on the intersection of opioid use, overdose and drug policy in Canada
15:00 – 15:15 Q&A
15:15 – 15:30 Break
15:30 – 15:45 Teresa Karrer (Roche, Basel)
Impact of the COVID-19 pandemic on routine clinical management of patients with neurological conditions: a retrospective cohort study in UK primary care (CPRD)
15:45 – 16:00 Kat Belendiuk (Roche, Basel)
Impact of the COVID-19 Pandemic on Healthcare Utilisation in US People Living with Multiple Sclerosis: an Analysis of the Flywheel MS Cohort.
16:00 – 16:25 Shivani Mhatre (Roche/Genentech, San Francisco)
Impact of the COVID-19 pandemic on oncology care patterns in the US and considerations for RWD study methodologies
16:25 – 16:30 Q&A/ Buffer
16:30 – 16:50 Andrea Burden (ETH Zurich)
Trends in opioid utilization and overdoses in Switzerland
16:50 – 17:10 Christoph Meier (University of Basel)
Drug utilization in Switzerland in the Covid pandemia: findings from a Swiss claims database
17:10 – 17:30 Discussion & Closure